Back to Search
JOSE CORTES, MD
MD
Family Medicine Physician
NPI: 1144858614IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
U0322(TX)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2016
Research & Publications (20)
T-Cell acute lymphoblastic leukemia with a "pinch" of BCR-ABL1.
PMID 19294558·Leuk Lymphoma·2009
8-other
Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience.
PMID 19340529·Int J Hematol·2009
8-other
Imatinib mesylate therapy for polycythemia vera: final result of a phase II study initiated in 2001.
PMID 19484334·Int J Hematol·2009
3-trial
Pharmacokinetic/pharmacodynamic correlation and blood-level testing in imatinib therapy for chronic myeloid leukemia.
PMID 19404318·Leukemia·2009
6-review
Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase.
PMID 18754032·Leukemia·2008
3-trial
Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis.
PMID 17185463·Blood·2007
3-trial
Staging of chronic myeloid leukemia in the imatinib era: an evaluation of the World Health Organization proposal.
PMID 16463391·Cancer·2006
8-other
Phase I study of BMS-214662, a farnesyl transferase inhibitor in patients with acute leukemias and high-risk myelodysplastic syndromes.
PMID 15728224·J Clin Oncol·2005
3-trial
Clonal evolution in chronic myelogenous leukemia.
PMID 15271399·Hematol Oncol Clin North Am·2004
6-review
Natural history and staging of chronic myelogenous leukemia.
PMID 15271393·Hematol Oncol Clin North Am·2004
6-review
Investigational strategies in chronic myelogenous leukemia.
PMID 15271396·Hematol Oncol Clin North Am·2004
6-review
Result of high-dose imatinib mesylate in patients with Philadelphia chromosome-positive chronic myeloid leukemia after failure of interferon-alpha.
PMID 12637317·Blood·2003
8-other
CMML: a biologically distinct myeloproliferative disease.
PMID 12901341·Curr Hematol Rep·2003
6-review
Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies.
PMID 12411300·Blood·2003
3-trial
Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy.
PMID 12560227·Blood·2003
3-trial
Farnesyltransferase inhibitors: novel compounds in development for the treatment of myeloid malignancies.
PMID 12214290·Semin Hematol·2002
6-review
Inhibition of IGF-IR tyrosine kinase induces apoptosis and cell cycle arrest in imatinib-resistant chronic myeloid leukaemia cells.
PMID 19508387·J Cell Mol Med·2010
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6487 BLANCO RD
SAN ANTONIO, TX 78216 - Phone
- (210) 921-3800
Quick Facts
- NPI
- 1144858614
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile